The American Medical Association had 180 scope of practice victories around the country, opposing incidents of groups practicing medicine without the proper background and training. However, its efforts to clamp down are being challenged. 

Statins appear to be the most impactful for patients diagnosed with hypertension or cerebrovascular disease.

The cuffless technology, which has already gained CE mark approval, should make its U.S. debut in 2026.

Care teams should be aware of this difference, even using CT images when possible to look for signs of any potential issues.

The new drug, LX2006, has already received the FDA's fast track designation. This latest distinction was based on early data from two separate clinical trials.

When doctors are accused of mishandling the heart health of a young athlete, it occasionally ends up being settled in a courtroom. 

The Heart Rhythm Society and its new advocacy arm plan on pushing CMS to include certain policy improvements in the 2026 MPFS.

The Siegel TAVR valve includes no nickel or cobalt. In fact, its frame was built using special alloys specifically developed by MiRus. 

Researchers with Mayo Clinic have shown that EHR-driven risk assessments could go a long way toward improving care for PCI patients. 

The FDA's 2024 approval of the Farapulse system covered patients with paroxysmal atrial fibrillation. Now, however, the technology is officially approved for patients with more persistent symptoms.